HCPCS J2781: Injection, pegcetacoplan, intravitreal, 1 mg
HCPCS Level II code J2781 describes the intravitreal injection formulation of pegcetacoplan, billed per 1 mg unit; this code represents administration of an ophthalmic complement inhibitor delivered via intravitreal injection as the service type, typically provided in an ophthalmology clinic, ambulatory surgery center, or hospital outpatient department for retinal disease management.
For related coverage guidance, see recent payer policy updates: Bendamustine Products Coverage Criteria, T-Cell Lymphoma Agents: Beleodaq, Istodax, Lymphir, Poteligeo, and Romidepsin, Brentuximab Vedotin (Adcetris®) Coverage Criteria.
Customize your policy alerts
Sign up for hcpcs J2781 policy alerts
Get alerted when payer policies referencing J2781 are released or updated.
Monitor payer policy activity